Literature DB >> 9371597

Repression of human immunodeficiency virus type 1 through the novel cooperation of human factors YY1 and LSF.

F Romerio1, M N Gabriel, D M Margolis.   

Abstract

A subpopulation of stably infected CD4+ cells capable of producing virus upon stimulation has been identified in human immunodeficiency virus (HIV)-positive individuals (T.-W. Chun, D. Finzi, J. Margolick, K. Chadwick, D. Schwartz, and R. F. Siliciano, Nat. Med. 1:1284-1290, 1995). Few host factors that directly limit HIV-1 transcription and could support this state of nonproductive HIV-1 infection have been described. YY1, a widely distributed human transcription factor, is known to inhibit HIV-1 long terminal repeat (LTR) transcription and virus production. LSF (also known as LBP-1, UBP, and CP-2) has been shown to repress LTR transcription in vitro, but transient expression of LSF has no effect on LTR activity in vivo. We report that both YY1 and LSF participate in the formation of a complex that recognizes the initiation region of the HIV-1 LTR. Further, we have found that these factors cooperate in the repression of LTR expression and viral replication. This cooperative function may account for the divergent effects of LSF previously observed in vitro and in vivo. Thus, the cooperation of two general cellular transcription factors may allow for the selective downregulation of HIV transcription. Through this mechanism of gene regulation, YY1 and LSF could contribute to the establishment and maintenance of a population of cells stably but nonproductively infected with HIV-1.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9371597      PMCID: PMC230241     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  29 in total

1.  Transcription factor LSF binds two variant bipartite sites within the SV40 late promoter.

Authors:  H C Huang; R Sundseth; U Hansen
Journal:  Genes Dev       Date:  1990-02       Impact factor: 11.361

2.  Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone.

Authors:  A Adachi; H E Gendelman; S Koenig; T Folks; R Willey; A Rabson; M A Martin
Journal:  J Virol       Date:  1986-08       Impact factor: 5.103

3.  Preparation of extracts from higher eukaryotes.

Authors:  J D Dignam
Journal:  Methods Enzymol       Date:  1990       Impact factor: 1.600

4.  Purification and characterization of FBI-1, a cellular factor that binds to the human immunodeficiency virus type 1 inducer of short transcripts.

Authors:  F Pessler; P S Pendergrast; N Hernandez
Journal:  Mol Cell Biol       Date:  1997-07       Impact factor: 4.272

5.  Introduction of foreign genes into tissues of living mice by DNA-coated microprojectiles.

Authors:  R S Williams; S A Johnston; M Riedy; M J DeVit; S G McElligott; J C Sanford
Journal:  Proc Natl Acad Sci U S A       Date:  1991-04-01       Impact factor: 11.205

6.  Repression of HIV-1 transcription by a cellular protein.

Authors:  H Kato; M Horikoshi; R G Roeder
Journal:  Science       Date:  1991-03-22       Impact factor: 47.728

7.  Structural arrangements of transcription control domains within the 5'-untranslated leader regions of the HIV-1 and HIV-2 promoters.

Authors:  K A Jones; P A Luciw; N Duchange
Journal:  Genes Dev       Date:  1988-09       Impact factor: 11.361

8.  Regulation of simian virus 40 early transcription in vitro by a purified tumor antigen.

Authors:  D Rio; A Robbins; R Myers; R Tjian
Journal:  Proc Natl Acad Sci U S A       Date:  1980-10       Impact factor: 11.205

9.  Trans-activation of the human immunodeficiency virus long terminal repeat sequence by DNA viruses.

Authors:  H E Gendelman; W Phelps; L Feigenbaum; J M Ostrove; A Adachi; P M Howley; G Khoury; H S Ginsberg; M A Martin
Journal:  Proc Natl Acad Sci U S A       Date:  1986-12       Impact factor: 11.205

10.  Interactions of cellular proteins involved in the transcriptional regulation of the human immunodeficiency virus.

Authors:  J A Garcia; F K Wu; R Mitsuyasu; R B Gaynor
Journal:  EMBO J       Date:  1987-12-01       Impact factor: 11.598

View more
  39 in total

1.  Statistical significance of clusters of motifs represented by position specific scoring matrices in nucleotide sequences.

Authors:  Martin C Frith; John L Spouge; Ulla Hansen; Zhiping Weng
Journal:  Nucleic Acids Res       Date:  2002-07-15       Impact factor: 16.971

2.  Combinatorial latency reactivation for HIV-1 subtypes and variants.

Authors:  John C Burnett; Kwang-Il Lim; Arash Calafi; John J Rossi; David V Schaffer; Adam P Arkin
Journal:  J Virol       Date:  2010-03-31       Impact factor: 5.103

Review 3.  Regulation of HIV-1 transcription.

Authors:  K A Roebuck; M Saifuddin
Journal:  Gene Expr       Date:  1999

4.  Efficient and specific targeting of Polycomb group proteins requires cooperative interaction between Grainyhead and Pleiohomeotic.

Authors:  András Blastyák; Rakesh K Mishra; Francois Karch; Henrik Gyurkovics
Journal:  Mol Cell Biol       Date:  2006-02       Impact factor: 4.272

5.  Determinants of the efficacy of HIV latency-reversing agents and implications for drug and treatment design.

Authors:  Ruian Ke; Jessica M Conway; David M Margolis; Alan S Perelson
Journal:  JCI Insight       Date:  2018-10-18

6.  Targeted derepression of the human immunodeficiency virus type 1 long terminal repeat by pyrrole-imidazole polyamides.

Authors:  Jason J Coull; Guocheng He; Christian Melander; Victor C Rucker; Peter B Dervan; David M Margolis
Journal:  J Virol       Date:  2002-12       Impact factor: 5.103

7.  Expression of latent HIV induced by the potent HDAC inhibitor suberoylanilide hydroxamic acid.

Authors:  Nancie M Archin; Amy Espeseth; Daniel Parker; Manzoor Cheema; Daria Hazuda; David M Margolis
Journal:  AIDS Res Hum Retroviruses       Date:  2009-02       Impact factor: 2.205

Review 8.  Molecular control of HIV-1 postintegration latency: implications for the development of new therapeutic strategies.

Authors:  Laurence Colin; Carine Van Lint
Journal:  Retrovirology       Date:  2009-12-04       Impact factor: 4.602

Review 9.  Latency reversal and viral clearance to cure HIV-1.

Authors:  David M Margolis; J Victor Garcia; Daria J Hazuda; Barton F Haynes
Journal:  Science       Date:  2016-07-22       Impact factor: 47.728

10.  Identification of genes conferring resistance to 5-fluorouracil.

Authors:  Byoung Kwon Yoo; Rachel Gredler; Nicollaq Vozhilla; Zao-zhong Su; Dong Chen; Talitha Forcier; Khalid Shah; Utsav Saxena; Ulla Hansen; Paul B Fisher; Devanand Sarkar
Journal:  Proc Natl Acad Sci U S A       Date:  2009-07-21       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.